UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

Nature communications, 2021-11, Vol.12 (1), p.6804-6804, Article 6804

2021

Volltextzugriff (PDF)

Histone deacetylase 10 promotes autophagy-mediated cell survival

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (28), p.E2592-E2601

2013

Volltextzugriff (PDF)

HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

Clinical cancer research, 2010-06, Vol.16 (12), p.3240-3252

2010

Volltextzugriff (PDF)

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma

Nucleic acids research, 2013-07, Vol.41 (12), p.6018-6033

2013

Volltextzugriff (PDF)

Targeting of HDAC8 and investigational inhibitors in neuroblastoma

Expert opinion on investigational drugs, 2009-11, Vol.18 (11), p.1605-1617

2009

Volltextzugriff (PDF)

A Deep Dive into the Circulating ctDNA Cosmos to Vanquish Neuroblastoma

Cancer discovery, 2022-12, Vol.12 (12), p.2727-2729

2022

Volltextzugriff (PDF)

Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain

Journal of molecular biology, 2004-02, Vol.336 (2), p.319-329

2004

Volltextzugriff (PDF)

HDAC11 is a novel drug target in carcinomas

International journal of cancer, 2013-05, Vol.132 (9), p.2200-2208

2013

Volltextzugriff (PDF)

Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

Clinical cancer research, 2022-05, Vol.28 (9), p.1809-1820

2022

Volltextzugriff (PDF)

Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma

Oncotarget, 2017-10, Vol.8 (49), p.85234-85251

2017

Volltextzugriff (PDF)

Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN‐amplified neuroblastoma

International journal of cancer, 2021-03, Vol.148 (5), p.1219-1232

2021

Volltextzugriff (PDF)

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

Cell death & disease, 2017-03, Vol.8 (3), p.e2635-e2635

2017

Volltextzugriff (PDF)

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment

Journal of neuro-oncology, 2012-12, Vol.110 (3), p.335-348

2012

Volltextzugriff (PDF)

Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model

International journal of cancer, 2020-02, Vol.146 (4), p.1031-1041

2020

Volltextzugriff (PDF)

Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction

The Journal of molecular diagnostics : JMD, 2020-11, Vol.22 (11), p.1309-1323

2020

Volltextzugriff (PDF)

Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas

Autophagy, 2013-12, Vol.9 (12), p.2163-2165

2013

Volltextzugriff (PDF)

GRHL1 Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3

Cancer research (Chicago, Ill.), 2014-05, Vol.74 (9), p.2604-2616

2014

Volltextzugriff (PDF)

Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma

Journal of clinical medicine, 2024-10, Vol.13 (19), p.5995

2024

Volltextzugriff (PDF)

Abstract 5679: Using droplet digital PCR to analyze MYCN copy number in plasma from patients with high-risk neuroblastoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5679-5679

2017

Volltextzugriff (PDF)

Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis

Journal of clinical medicine, 2024-10, Vol.13 (20), p.6081

2024

Volltextzugriff (PDF)

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma

Acta neuropathologica communications, 2015-04, Vol.3 (1), p.22-22, Article 22

2015

Volltextzugriff (PDF)

Nestin Expression Identifies Ependymoma Patients with Poor Outcome

Brain pathology (Zurich, Switzerland), 2012-11, Vol.22 (6), p.848-860

2012

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieActa Neuropathologica

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Humans
(25)
Oncology
(12)
Neuroblastoma - Genetics
(10)
Neuroblastoma
(9)
Neuroblastoma - Pathology
(8)
Tumors
(8)
Animals
(7)
Cancer
(6)
Cell Line, Tumor
(6)
Female
(6)
Histone Deacetylase Inhibitors - Pharmacology
(6)
Male
(6)
Biochemistry & Molecular Biology
(5)
Biological And Medical Sciences
(5)
Cell Death
(5)
Child
(5)
Histone Deacetylases - Metabolism
(5)
Mice
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

Histone deacetylase 10 promotes autophagy-mediated cell survival

HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma

Targeting of HDAC8 and investigational inhibitors in neuroblastoma

A Deep Dive into the Circulating ctDNA Cosmos to Vanquish Neuroblastoma

Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain

HDAC11 is a novel drug target in carcinomas

Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma

Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells

Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN‐amplified neuroblastoma

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment

Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model

Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction

Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas

GRHL1 Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3

Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma

Abstract 5679: Using droplet digital PCR to analyze MYCN copy number in plasma from patients with high-risk neuroblastoma

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics

Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Nestin Expression Identifies Ependymoma Patients with Poor Outcome

Aktive Filter

Suchergebnisse filtern